Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

High doses of Antisecreto… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

High doses of Antisecretory Factor stop diarrhea fast without recurrence for six weeks post treatment

Artikel i vetenskaplig tidskrift
Författare S. Zaman
K. Aamir
Lars Åke Hanson
Stefan Lange
Publicerad i International Journal of Infectious Diseases
Volym 71
Sidor 48-52
ISSN 1201-9712
Publiceringsår 2018
Publicerad vid Institutionen för biomedicin
Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Sidor 48-52
Språk en
Länkar https://doi.org/10.1016/j.ijid.2018...
Ämnesord Paediatric diarrheal disease, Antisecretory Factor, Developing country, Recovery time, Follow up, inflammatory-bowel-disease, childhood diarrhea, menieres-disease, trial, food, Infectious Diseases
Ämneskategorier Pediatrik, Infektionsmedicin

Sammanfattning

Background: Diarrheal illnesses in young children cause morbidity and preventable deaths in developing countries. We evaluated two high doses of Salovum (R) [Antisecretory Factor] to treat diarrhea in young children and followed up for recurrence 6 weeks post treatment. Methods: Forty children, 6-24 months old, admitted with acute diarrhea, to the Outpatient Department of Children's Hospital in Lahore, Pakistan were selected. The patients were randomly allocated to either Group A given 2 sachets, or to Group B, given 4 sachets. Each sachet contained 4 gram of Salovum (R) and was mixed with Oral Rehydration Salt solution. This mixture was administered perorally within the first 30 min of treatment. The trained nursing staff observed them for number of stools and consistency over every half hour for a total of 4 hours. Follow up for 6 weeks was done daily by telephone, or visits by the mothers. The results demonstrate that Salovum (R) provides a protective effect irrespective of the diarrhea causes. Results: Group B, given 4 sachets of Salovum (R) showed improved fecal consistency in 80% of the children compared to 50% in Group A within 30 minutes of treatment, p= 0.004. The number of diarrheal stools decreased over this time from seven to one/two over 4 hours in the two groups [p = 0.234]. None of the children showed a recurrence of diarrhea over the follow up period. Conclusion: Peroral high doses of Salovum (R) rapidly and safely counteract diarrhea in children followed by a diarrhea-free period of 6 weeks. (C) 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?